Feline Upper Respiratory Tract Infections: Differential Diagnosis Using Multiplex PCR Panels

Introduction

Feline upper respiratory tract infection (URTI) represents a complex clinical syndrome with overlapping signs including conjunctivitis, rhinitis, sneezing, and ocular discharge. The primary etiological agents are feline herpesvirus 1 (FHV-1), feline calicivirus (FCV), Chlamydia felis, and Bordetella bronchiseptica [5, 11, 15]. Coinfections are common, and clinical differentiation is unreliable. Multiplex polymerase chain reaction (PCR) panels offer simultaneous detection of these pathogens with high sensitivity and specificity, enabling targeted antimicrobial and antiviral therapy. This article reviews the biological principles of the target pathogens, optimal sample collection methods, multiplex PCR assay physics, and strategies for interpreting cycle threshold (Ct) values in a feline URTI differential diagnosis algorithm.

Pathogen Biology and Clinical Significance

Feline Herpesvirus 1 (FHV-1)

FHV-1 is an enveloped, double-stranded DNA virus of the family Herpesviridae, subfamily Alphaherpesvirinae. It exhibits tropism for mucosal epithelia of the upper respiratory tract and conjunctiva. Following acute infection, the virus establishes latent infection in trigeminal ganglia with periodic reactivation under stress. The replication cycle involves viral DNA replication in the nucleus, utilizing host RNA polymerase II and viral DNA polymerase. Multiplex PCR targets conserved regions of the thymidine kinase (TK) gene or glycoprotein B (gB) gene [11]. Fluorescent microsphere-based immunochromatographic methods have also been developed for rapid antigen detection, but molecular amplification remains the reference standard [11].

Feline Calicivirus (FCV)

FCV is a nonenveloped, single-stranded positive-sense RNA virus of the family Caliciviridae. The icosahedral capsid is composed of VP1 protein, which contains hypervariable regions responsible for antigenic diversity. The virus infects oral and respiratory epithelium and causes vesicular lesions on the tongue and palate. Systemic virulent strains (VS-FCV) can cause severe pneumonia and edema. The RNA-dependent RNA polymerase lacks proofreading, resulting in high mutation rates that complicate vaccine efficacy. Multiplex PCR assays often target the ORF1 region or the capsid gene for detection [15]. Recent advances include engineered mRNA vaccines targeting the VP1 capsid protein, demonstrating complete protection in experimental models [15].

Chlamydia felis

Chlamydia felis is an obligate intracellular gram-negative bacterium belonging to the Chlamydiaceae family. The biphasic lifecycle alternates between infectious elementary bodies (EBs) and replicative reticulate bodies (RBs) within host cell vacuoles. The organism predominantly targets conjunctival epithelial cells, causing severe conjunctivitis that can progress to keratitis. The outer membrane protein A (ompA) gene and the cryptic plasmid are common PCR targets. Because C. felis is highly fastidious, culture is rarely performed; molecular detection is essential for confirmation.

Bordetella bronchiseptica

Bordetella bronchiseptica is a gram-negative aerobic coccobacillus that colonizes ciliated respiratory epithelium. It expresses adhesins such as filamentous hemagglutinin and pertactin, and produces toxins including tracheal cytotoxin and dermonecrotic toxin, which impair mucociliary clearance. This pathogen is commonly coisolated with viruses in multicat environments. PCR targets include the flagellin gene (fla) or the adenylate cyclase toxin gene (cyaA). Antimicrobial susceptibility testing is advisable due to increasing resistance [9].

Sample Collection and Handling

Optimal specimen quality directly affects multiplex PCR performance. Gentle conjunctival swabbing using sterile polyester or flocked nylon swabs is recommended. For maximum sensitivity, swabs should be rotated against the lower conjunctival fornix and the nictitating membrane to collect epithelial cells harboring intracellular organisms such as C. felis. Nasal and oropharyngeal swabs may be added for comprehensive coverage, especially when lower respiratory signs are present.

Collection medium should be sterile phosphate-buffered saline (PBS) or viral transport medium (VTM) without preservatives that inhibit PCR. Samples should be refrigerated at 4 degrees Celsius for short term storage (less than 48 hours) or frozen at minus 80 degrees Celsius for longer intervals. Repeated freeze-thaw cycles degrade nucleic acid and should be avoided.

Multiplex PCR Panel Design and Physics

Multiplex PCR uses multiple primer sets within a single reaction tube to amplify several target sequences simultaneously. The key biophysical considerations are:

• Primer design: Melting temperatures must be within 2 degrees Celsius of each other to avoid differential amplification efficiency. Primer dimers and cross-hybridization are minimized through computational design algorithms.
• Detection chemistries: TaqMan probes with distinct fluorophores (e.g., FAM for FHV-1, VIC for FCV, ROX for C. felis, Cy5 for B. bronchiseptica) allow real-time monitoring of each target.
• Internal controls: An exogenous internal amplification control (IAC) spiked into each sample detects PCR inhibition. A separate probe with a distinct fluorophore (e.g., JOE) targets the IAC.
• Thermal cycling parameters: Denaturation at 95 degrees Celsius, annealing at 55-60 degrees Celsius, and extension at 72 degrees Celsius. Cycling numbers are typically 40-45.

The reaction consists of DNA polymerase (for DNA pathogens) and reverse transcription step (for RNA viruses such as FCV). Reverse transcription is performed with random hexamers or oligo-dT primers, followed by PCR with target-specific primers.

The exponential amplification equation is:

[N = N_0 (1 + E)^C]

where N is the amplicon number, N_0 is the initial target copy number, E is amplification efficiency (optimal near 1.0), and C is cycle number. The Ct value is the cycle at which the fluorescence signal exceeds a threshold, typically set at 10 standard deviations above baseline.

Interpretation of Cycle Threshold (Ct) Values

Ct values are inversely proportional to the logarithm of the initial target nucleic acid concentration. A lower Ct indicates higher viral or bacterial load. Interpretation must account for sample quality, collection technique, and the pathogen's biological niche.

The following table provides general guidance for Ct value interpretation in feline URTI multiplex panels:

Important caveats:

• For intracellular pathogens like C. felis, low organism numbers in the swab matrix may yield Ct values in the 30-35 range even in true infection. A second sterile swab or cytology may aid confirmation.
• FCV shedding can persist for weeks after clinical resolution, so a low Ct for FCV may reflect previous exposure rather than current disease.
• FHV-1 reactivation can produce low Ct values without significant clinical signs in previously exposed cats.
• For B. bronchiseptica, moderate to high loads (Ct < 28) correlate with clinical disease in kittens, while subclinical carriers may have Ct > 32.

Differential Diagnosis Algorithm

The following Mermaid diagram illustrates a decision tree for interpreting multiplex PCR results in cats presenting with URTI signs:

graph TD
    A[Cat with URTI signs], > B[Collect conjunctival and nasal swabs]
    B, > C[Multiplex PCR for FHV-1, FCV, C. felis, B. bronchiseptica]
    C, > D{Any pathogen detected?}
    D, >|No| E[Consider non-infectious causes: allergy, fungal granuloma, nasal foreign body, neoplasia]
    D, >|Yes| F{Multiple pathogens?}
    F, >|No| G[Single pathogen identified]
    F, >|Yes| H[Coinfection - treat all detected pathogens]
    G, > I[Compare Ct value with clinical severity]
    I, > J{Ct < 28?}
    J, >|Yes| K[Primary pathogen - initiate targeted therapy]
    J, >|No| L[Ct 28-35 - assess likelihood; consider carrier state vs. early infection]
    L, > M[Repeat swab in 48-72 hours if no improvement]
    K, > N[Monitor response; recheck if no improvement in 7 days]
    H, > O[Treat per antimicrobial guidelines; consider mixed infection complexity]
    O, > P[Re-evaluate after full treatment course]

Coinfections and Dual Pathogen Dynamics

Coinfections are detected in 20-40% of feline URTI cases. The presence of FHV-1 with C. felis or FCV with B. bronchiseptica is common in multicat environments. Multiplex PCR uniquely identifies such coinfections, which can complicate treatment because antiviral agents (e.g., famciclovir) do not affect bacteria, and doxycycline has no activity against viruses. The simultaneous detection of two or three pathogens requires a combined therapeutic approach and strict biosecurity measures.

Limitations of Multiplex PCR

Despite high sensitivity, multiplex PCR has limitations:

• The assay cannot differentiate between infectious and noninfectious organisms (degraded nucleic acid may be detected).
• Mutations in primer binding sites (especially for hypervariable RNA viruses like FCV) can lead to false negatives.
• Sample inhibition (e.g., from hemoglobin, mucus, or topical ophthalmic medications) may cause false negatives flagged by the IAC.
• Multiplex panels typically only cover the four core pathogens; other agents such as Mycoplasma felis, Cryptococcus species [8], Nocardia species [7], Rickettsia felis [6], and even Mycobacterium orygis [13] can cause URTI-like signs. In cases where multiplex PCR is negative, advanced diagnostics such as targeted next-generation sequencing (tNGS) may be warranted [6].

Integration with Other Diagnostic Modalities

The multiplex PCR result should be interpreted in the context of complete blood count (use automated impedance analyzers), cytology of conjunctival swabs, and serological testing for retroviral coinfections such as feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). Cats with immunosuppression are more prone to severe or atypical URTI. Additionally, thoracic radiography is indicated if lower respiratory signs are present, as pathogens such as B. bronchiseptica can cause pneumonia.

The utility of multiplex PCR panels is enhanced when combined with concentration testing for noninfectious differentials. For example, positive PCR for FHV-1 in a cat with chronic sneezing may warrant rhinoscopy to rule out structural lesions.

Future Directions

Advances in point-of-care molecular diagnostics, including isothermal amplification and microfluidic PCR, are enabling same-day multiplex testing in clinic settings. These platforms reduce turnaround time and allow earlier treatment decisions. Additionally, metagenomic sequencing approaches are beginning to identify previously unrecognized viral co-pathogens, such as gammaherpesviruses, that may contribute to the URTI complex [5].

Conclusion

Multiplex PCR panels represent a cornerstone of evidence-based differential diagnosis for feline upper respiratory tract infections. Proper sample collection, awareness of pathogen-specific shedding patterns, and careful interpretation of Ct values are essential for maximizing diagnostic accuracy. The integration of molecular results with clinical and cytological findings allows veterinarians to distinguish primary infection from carrier states, guide appropriate antiviral or antimicrobial therapy, and improve outcomes in the increasingly complex landscape of feline respiratory disease.

References

1. Dressler A, Wagner-Wiening C, Tegtmeyer B, et al. Highly pathogenic avian influenza A(H5N1) in poultry and domestic cats and occupational exposure among veterinary and other first responders, Germany, February 2026. Euro Surveill. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42141860/

2. Sasvari H, Sherry L, Logan N, et al. Serological response to feline coronavirus in the UK domestic cat population. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42138717/

3. Du YT, Hu X, Zhu ZG, et al. The impact of nonpharmaceutical interventions (NPIs) on rabies post-exposure prophylaxis: A comparative study in Wuhan, 2022 vs. 2023. Hum Vaccin Immunother. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42116803/

4. Vaughan A, Joyce A, Traub E, et al. Serologic Evidence of Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Veterinary Professional Exposed to an Infected Domestic Cat - Los Angeles County, California, December 2024-January 2025. MMWR Morb Mortal Wkly Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42096344/

5. Doğan F, Acar G, Fedai T, et al. Investigation of the presence of gammaherpesvirus infections in cats with and without upper respiratory tract disease. Comp Immunol Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42035571/

6. Bai Y, Zhao J, Wang Z, et al. A case of Rickettsia felis caused pneumonia and diagnosed by clinical analysis and Targeted Next-Generation Sequencing (tNGS) using Bronchoalveolar Lavage Fluid (BALF): A case report and literature review. J Infect Public Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41935438/

7. Foster A, Kerr M, Gu J. Sinonasal Nocardia farcinica in a cat with comorbidities. Can Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41929723/

8. Dzimira S. Feline Cryptococcosis: Two Case Reports and a Literature Review. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41901732/

9. Foksiński P, Kaczorek-Łukowska E, Szyryńska N, et al. Preliminary study on the effects of sub-MIC concentrations of octenidine and polyhexanidine on biofilms produced by animal isolates of Pseudomonas aeruginosa. BMC Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41888683/

10. Kaur J, Giannino D, Taylor R, et al. Nodular pyogranulomatous pneumonia associated with Besnoitia darlingi infection in a cat. J Vet Diagn Invest. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41782300/

11. Shao P, Lian Y, Liu X, et al. Rapid and sensitive detection of feline herpesvirus-1 using fluorescent microspheres as labels for immunochromatographic test strips. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41779066/

12. Nooruzzaman M, Butt SL, Rani R, et al. The ORF6 accessory protein contributes to SARS-CoV-2 virulence and pathogenicity in the naturally susceptible feline model of infection. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41757964/

13. Mitra N, Jadhao A, Dhende AV, et al. First report of fatal feline pulmonary tuberculosis caused by the emerging zoonotic pathogen Mycobacterium orygis in a cat from India. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41712109/

14. Yuan Y, Geng Y, Zhu Q, et al. Comparable immune escape capacity for NB.1 with that of JN.1 variant and survey of infection with severe acute respiratory syndrome coronavirus 2 variants among Chinese Felis silvestris catus. Front Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41676134/

15. Zhang MD, Xie ZF, Li XH, et al. Engineered VP1 mRNA Vaccine Induces Immunity and Complete Protection Against Feline Calicivirus in Cats. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41658352/